Rhythm Pharmaceuticals (RYTM) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Rhythm Pharmaceuticals (RYTM) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Rhythm Pharmaceuticals

· RYTM

Dashboard

Financials

KPIs

Ratios

Transcripts

Valuation

Statistics

6.59 B

-0.52%

General

Market Cap: $6.59B
Enterprise Value: $6.47B
Shares Outstanding: 68,530,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 89.00%
Operating Margin: -83.62%
Net Profit Margin: -85.59%
FCF Margin: -62.72%
ROA: -46.96%
ROE: -80.48%
ROIC: -63.82%
Current Ratio: 3.45
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: -9.27
P/S: 27.22
P/FCF: —
P/B: 30.06
EV/EBITDA: -35.02

Growth

Rev 1Y: 45.83%
Rev 1Y Fwd Est: 67.02%
Rev 3Y (CAGR): 100.23%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $239.92M
Gross Margin: 89.00%
Operating Expenses: $414.16M
Operating Income: -$200.63M
Net Profit: -$205.35M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $65.61M
Working Capital: $302.98M
Total Assets: $437.27M
Net Debt: -$61.93M
Total Liabilities: $219.97M
Total Equity: $217.3M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$149.53M
Cash Flow from Investing: -$87.88M
Cash Flow from Financing: $174.39M
Free Cash Flow: -$150.49M
Capital Expenditures: $953K